Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Rheumatology · Behçet's disease

Is Behçet's Disease More Severe in Young Men?

At a Glance

Yes, young men who develop Behçet's disease before age 25 often experience more severe symptoms. They face a higher risk of serious eye inflammation, blood clots, and neurological issues. Early, aggressive treatment with immunosuppressants or biologics is critical to prevent long-term damage.

Statistically, yes—young men who develop symptoms of Behçet’s disease before age 25 have a higher risk of experiencing a more severe form of the condition [1][2]. Research shows that early-onset Behçet’s disease (beginning before the mid-twenties) and being male are both associated with more frequent and intense disease activity [1][3][4]. However, this does not mean every young man with Behçet’s will have severe complications. Rather, it means that if you fit this demographic, your care team needs to be more proactive with screening and more aggressive with early treatment to protect your long-term health [1][5].

Understanding the Risks

While Behçet’s disease can affect anyone, the way it shows up can differ based on age and sex. For young men, the increased severity typically involves specific areas:

  • Eye Involvement (Ocular Manifestations): Young men are at a higher risk for persistent and severe eye inflammation, particularly uveitis (inflammation of the middle layer of the eye) and retinal vasculitis (inflammation of the blood vessels in the back of the eye) [1][6][7]. These conditions can threaten vision if not treated promptly [8].
  • Blood Vessel Involvement (Vascular Manifestations): Vascular issues, such as blood clots (thrombosis) and weakened, bulging blood vessels (aneurysms), are significantly more common and tend to be more severe in male patients [2][9]. Cardiac involvement, although rare, is also a higher risk for young men [10][11].
  • Neurological Involvement (Neuro-Behçet’s): Severe central nervous system involvement is historically more common or severe in male patients [12].

The underlying reasons for these differences are still being studied, but researchers believe that male patients may have a higher genetic risk profile that contributes to these clinical differences [13].

Red Flag Symptoms to Watch For

Because of these risks, it is critical to know what a severe complication feels like so you can seek emergency medical care immediately. Do not ignore these symptoms:

  • Sudden eye pain, redness, or changes in vision (like blurriness or floaters)
  • Unexplained swelling, pain, or warmth in your arms or legs (which could indicate a blood clot)
  • Sudden or severe chest or abdominal pain
  • Severe or unusual headaches, confusion, or difficulty with balance

What This Means for Your Care Plan

Hearing that you are at a higher risk for severe symptoms can be frightening, but this knowledge is actually a powerful tool. It allows your healthcare providers to tailor a care plan that stays one step ahead of the disease.

For young men, a proactive approach typically includes:

  • Aggressive Early Treatment: Rather than waiting for symptoms to worsen, doctors may quickly start treatments using immunosuppressive drugs or biologic therapies (medications that target specific parts of the immune system, like adalimumab or infliximab) [14][15]. Early use of these medications is critical for preserving vision and preventing life-threatening vascular complications [5][6].
  • Frequent Screenings: You will likely need regular check-ups with specialists. This includes frequent comprehensive eye exams by an ophthalmologist, even if your vision seems fine, to catch inflammation early [1].
  • Targeted Imaging: Your team may perform thorough clinical exams or use targeted imaging, such as vascular ultrasounds, to evaluate specific blood vessels if they suspect involvement [16][17].

While the statistics highlight increased risks for young men, modern therapies are highly effective at managing Behçet’s disease when started early [15]. By working closely with a knowledgeable medical team, you can take control of your health and significantly reduce the risk of long-term complications.

Common questions in this guide

Why is Behçet's disease considered more severe in young men?
Young men who develop Behçet's before age 25 have a higher risk of frequent and intense disease activity. This often involves a greater risk of severe eye, vascular, and neurological complications compared to other demographics.
What red flag symptoms should young men with Behçet's disease watch out for?
Critical red flag symptoms include sudden eye pain or vision changes, unexplained swelling or warmth in the limbs, sudden chest or abdominal pain, and severe headaches. These can indicate serious complications like blood clots or severe inflammation requiring immediate emergency care.
How frequently should young men with Behçet's disease see an eye doctor?
Young men with Behçet's are at high risk for eye inflammation like uveitis and should have regular comprehensive exams with an ophthalmologist. These frequent check-ups are crucial to catch and treat inflammation early, even if your vision currently seems fine.
What treatments are used for severe Behçet's disease in young men?
Doctors often take an aggressive, early approach using immunosuppressive drugs or biologic therapies. Medications like adalimumab or infliximab help target the immune system to prevent life-threatening complications and preserve vision.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my age and sex, how frequently should I be seeing an ophthalmologist for comprehensive eye exams?
  2. 2.Are there specific baseline imaging tests or vascular screenings we should perform to establish my vascular health?
  3. 3.What is our threshold for starting biologic therapies or immunosuppressants instead of standard treatments?
  4. 4.If I experience a red flag symptom like sudden leg swelling or vision changes, should I go straight to the emergency room or call your office first?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Relationship between age at onset and clinical characteristics of Behçet's disease.

    Ghembaza MEA, Lounici A

    Acta dermatovenerologica Alpina, Pannonica, et Adriatica 2018; (27(4)):175-177.

    PMID: 30564829
  2. 2

    Behçet's disease: How to diagnose and treat vascular involvement.

    Seyahi E

    Best practice & research. Clinical rheumatology 2016; (30(2)):279-295 doi:10.1016/j.berh.2016.08.002.

    PMID: 27886800
  3. 3

    Cutaneous and Extracutaneous Manifestations of Behçet's Disease Linked to Its Disease Activity and Prognosis.

    Limtong P, Chanprapaph K, Vachiramon V, Ngamjanyaporn P

    Clinical, cosmetic and investigational dermatology 2020; (13()):639-647 doi:10.2147/CCID.S265169.

    PMID: 32904702
  4. 4

    Age-related differences in the clinical phenotypes of Behçet's disease: The experience of two referral centres.

    Tekgöz N, Tekgöz E, Çolak S, et al.

    Modern rheumatology 2023; (34(1)):194-200 doi:10.1093/mr/road012.

    PMID: 36688579
  5. 5

    Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study.

    Fabiani C, Vitale A, Emmi G, et al.

    Clinical rheumatology 2017; (36(1)):183-189 doi:10.1007/s10067-016-3480-x.

    PMID: 27853889
  6. 6

    [Behçet's disease : Description and analysis of a French single-center retrospective study of 51 patients].

    Francois J, Moulinet T, Neiter E, et al.

    Journal francais d'ophtalmologie 2021; (44(5)):711-717 doi:10.1016/j.jfo.2020.04.064.

    PMID: 33741217
  7. 7

    [Behçet's disease and uveitis].

    Razumova IY, Godzenko AA

    Vestnik oftalmologii 2021; (137(5)):130-137 doi:10.17116/oftalma2021137051130.

    PMID: 34726867
  8. 8

    Uveitis in paediatric Behçet disease: a large multicentric Italian cohort.

    Maccora I, Orsini SI, Gallizzi R, et al.

    Therapeutic advances in musculoskeletal disease 2024; (16()):1759720X241275822 doi:10.1177/1759720X241275822.

    PMID: 39650333
  9. 9

    Pulmonary artery thrombosis as the first presentation of Behçet's syndrome: a case report and review of the literature.

    Alakkas Z, Kazi W, Mattar M, et al.

    Journal of medical case reports 2021; (15(1)):322 doi:10.1186/s13256-021-02931-1.

    PMID: 34154640
  10. 10

    Cardiac involvement of Behcet's disease in children: a single-center study from Turkey.

    Beyazal M, Şenturk CÇ, Yoğun SN, et al.

    European journal of pediatrics 2025; (184(6)):335 doi:10.1007/s00431-025-06149-x.

    PMID: 40353904
  11. 11

    Vasculo-Behçet's disease with a giant pseudoaneurysm of superficial femoral artery: A case report.

    Al-Doud MA, Al-Nusairat AN, Al-Shanableh NM, et al.

    International journal of surgery case reports 2023; (109()):108534 doi:10.1016/j.ijscr.2023.108534.

    PMID: 37524014
  12. 12

    Metabolomic alterations associated with Behçet's disease.

    Zheng W, Wu X, Goudarzi M, et al.

    Arthritis research & therapy 2018; (20(1)):214 doi:10.1186/s13075-018-1712-y.

    PMID: 30249301
  13. 13

    Sex-specific analysis in Behçet's disease reveals higher genetic risk in male patients.

    Jo YG, Ortiz-Fernández L, Coit P, et al.

    Journal of autoimmunity 2022; (132()):102882 doi:10.1016/j.jaut.2022.102882.

    PMID: 35987173
  14. 14

    Early administration of adalimumab for paediatric uveitis due to Behçet's disease.

    Hiyama T, Harada Y, Doi T, Kiuchi Y

    Pediatric rheumatology online journal 2019; (17(1)):29 doi:10.1186/s12969-019-0333-6.

    PMID: 31182107
  15. 15

    Isolated brachial artery aneurysm: a rare presentation of paediatric Behçet's disease.

    Naik AL, Savlania A, Gupta A, et al.

    Annals of the Royal College of Surgeons of England 2021; (103(3)):e94-e97 doi:10.1308/rcsann.2020.7037.

    PMID: 33645285
  16. 16

    Treatment of Behçet's Disease: An Algorithmic Multidisciplinary Approach.

    Alpsoy E, Leccese P, Emmi G, Ohno S

    Frontiers in medicine 2021; (8()):624795 doi:10.3389/fmed.2021.624795.

    PMID: 33996847
  17. 17

    Cardiac magnetic resonance imaging in patients with Behçet's disease.

    Ahmed AA, Tharwat S, Batouty NM, et al.

    Advances in rheumatology (London, England) 2021; (61(1)):74 doi:10.1186/s42358-021-00230-3.

    PMID: 34876236

This page explains the risks and management of early-onset Behçet's disease in young men for educational purposes. Always consult your rheumatologist or specialist for personalized medical advice and treatment.

Get notified when new evidence is published on Behçet disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.